Valeant Pharmaceuticals International Graphic Designer Salaries in Wilmington, DE
The average Valeant Pharmaceuticals International Graphic Designer in Wilmington, DE earns an estimated $78,830 annually, which includes an estimated base salary of $71,875 with a $6,955 bonus. Valeant Pharmaceuticals International's Graphic Designer compensation is $18,136 more than the US average for a Graphic Designer. Graphic Designer salaries at Valeant Pharmaceuticals International in Wilmington, DE can range from $40,000 - $168,000.
In Wilmington, DE, The Design Department at Valeant Pharmaceuticals International earns $4,860 more on average than the HR Department.
Last updated 2 years ago.
- $71,875
- avg. base
- $6,955
- avg. bonus
Graphic Designer Salaries at Valeant Pharmaceuticals International
In Wilmington, DE, Graphic Designers earn $2,850 more than Graphic Designers, and $13,284 less than UI/UX Designers.
Compensation at Valeant Pharmaceuticals International by Department
In Wilmington, DE, The Design Department averages $4,860 more than the HR Department, and $5,956 less than the Sales Department
Graphic Designer Compensation by Gender (All Companies)
The average female Graphic Designer at companies similar size to Valeant Pharmaceuticals International reported making $80,485, while the average male Graphic Designer at similar sized companies reported making $96,847.
Graphic Designer Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Graphic Designer at companies similar size to Valeant Pharmaceuticals International reported making $106,875, while the average African American/Black Graphic Designer at similar sized companies reported making $53,000.
How Graphic Designers at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Graphic Designers at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Graphic Designers at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
